Raza Hasan, Naffouj Sandra, Guzman Grace, Shuja Asim
Department of Medicine, University of Illinois, Chicago, IL.
Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois, Chicago, IL.
ACG Case Rep J. 2024 Feb 28;11(3):e01281. doi: 10.14309/crj.0000000000001281. eCollection 2024 Mar.
Graft-vs-host disease (GVHD) of the gastrointestinal (GI) tract is notably a serious complication of allogeneic hematopoietic stem cell transplant (HSCT). However, GI GVHD has rarely been reported in autologous HSCT, and the pathophysiology remains unclear. Diagnosing GVHD after autologous HSCT requires a high level of clinical suspicion, given its nonspecific clinical presentation and endoscopic findings necessitating a histological diagnosis for confirmation. We present a case of autologous GVHD involving the GI tract in a patient with multiple myeloma who responded well to corticosteroids, highlighting the importance of early identification of this rare entity to initiate therapy and improve outcomes.
胃肠道移植物抗宿主病(GVHD)是异基因造血干细胞移植(HSCT)的一种严重并发症。然而,胃肠道GVHD在自体HSCT中鲜有报道,其病理生理学仍不清楚。鉴于自体HSCT后GVHD的临床表现和内镜检查结果不具有特异性,需要组织学诊断来确诊,因此诊断需要高度的临床怀疑。我们报告了一例患有多发性骨髓瘤的患者发生的累及胃肠道的自体GVHD病例,该患者对皮质类固醇反应良好,强调了早期识别这种罕见疾病以启动治疗并改善预后的重要性。